A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck

Clinical trial NCT01177956 · COMPLETED

Trial details

NCT number: NCT01177956
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2009-12-01
Primary completion: 2011-01-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.